STEMart announces the expansion of its genetic toxicology capabilities with the In Vivo Rat Micronucleus Test services.
STEMart, a US-based provider of comprehensive services for all phases of medical device development, has announced the availability of its robust In Vitro Micronucleus Test service to meet the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results